BALA MOHAN (SVP, Chief Development Officer) sold 3.3% of their position (1.88K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/29/2024ACC: 0001104659-24-112267
Officer· SVP, Chief Development Officer
Since Sep 2023
-1.88K
Net shares
Net seller
$3.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.25K acquired · 8.13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
12.4%
10/25/2024
50.37K→56.62K
Common Stock
Direct
Shares
−1.88K
Price / share
$1.90
Trade value
$3.58K
% of position
3.3%
10/28/2024
56.62K→54.73K
Total
Net shares
+4.37K
Net value
-$3.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/25/2024 | M · Option Exercise | +6.25K | — | — | 12.4% | 50.37K | 56.62K |
| Common Stock Direct | 10/28/2024 | S · Sale | −1.88K | $1.90 | $3.58K | 3.3% | 56.62K | 54.73K |
| Total | +4.37K | -$3.58K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
6.25K
Exercisable
—
10/25/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock6.25K shares | 10/25/2024 | M · Option Exercise | −6.25K | — | 6.25K |